Niagen Bioscience (NAGE) Intangibles (2011 - 2026)
Niagen Bioscience (NAGE) reported Intangibles of $5.5 million for Q1 2026, up 1603.42% year-over-year from $322000.0 in Q1 2025, and down 3.09% quarter-over-quarter from $5.7 million in Q4 2025.
Niagen Bioscience (NAGE) Intangibles (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 15 years of Intangibles data on file, last reported at $5.5 million in Q1 2026.
- Intangibles for Q1 2026 came in at $5.5 million, up 1603.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.5 million (up 1603.42% YoY), and the FY2025 annual result was $5.7 million, up 1476.6% from the prior year.
- Intangibles eased to $5.5 million in Q1 2026 per NAGE's latest filing, from $5.7 million in the prior quarter.
- Over five years, Intangibles peaked at $5.7 million in Q4 2025 and troughed at $246000.0 in Q3 2025.
- A 5-year average of $1.1 million and a median of $552000.0 in 2023 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles sank 38.04% in 2025, then surged 1603.42% in 2026.
- A 5-year view of Intangibles shows it stood at $671000.0 in 2022, then slipped by 23.99% to $510000.0 in 2023, then decreased by 29.61% to $359000.0 in 2024, then soared by 1476.6% to $5.7 million in 2025, then slipped by 3.09% to $5.5 million in 2026.
- Business Quant data shows NAGE's Intangibles at $5.5 million in Q1 2026, $5.7 million in Q4 2025, and $246000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.49 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 284,000.00 |
| Mar 31, 2025 | 322,000.00 |
| Dec 31, 2024 | 359,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 435,000.00 |
| Mar 31, 2024 | 472,000.00 |
| Dec 31, 2023 | 510,000.00 |
| Sep 30, 2023 | 552,000.00 |
| Jun 30, 2023 | 591,000.00 |
| Mar 31, 2023 | 630,000.00 |
| Dec 31, 2022 | 671,000.00 |
| Sep 30, 2022 | 714,000.00 |
| Jun 30, 2022 | 758,000.00 |
| Mar 31, 2022 | 808,000.00 |
| Dec 31, 2021 | 857,000.00 |
| Sep 30, 2021 | 908,000.00 |
| Jun 30, 2021 | 961,000.00 |